CITANEST FORTE DENTAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Citanest Forte Dental, and what generic alternatives are available?
Citanest Forte Dental is a drug marketed by Dentsply Pharm and is included in one NDA.
The generic ingredient in CITANEST FORTE DENTAL is epinephrine bitartrate; prilocaine hydrochloride. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
US Patents and Regulatory Information for CITANEST FORTE DENTAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dentsply Pharm | CITANEST FORTE DENTAL | epinephrine bitartrate; prilocaine hydrochloride | INJECTABLE;INJECTION | 021383-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
